It would be wise to get confirmation that you truly are a chronic Staph carrier before proceeding with antibiotic or any other therapy. Even if the nasal cultures are inconstantly positive for Staph, you would ideally want to consult with an Infectious Disease consultant before initiating chronic treatment.
The nasal dryness you describe is also consistent with a condition called, atrophic rhinitis. A great number of therapies have been reported in the medical literature but it is my understanding that there is no truly definitive treatment of this condition.
However, given the divergence of opinions expressed by your ENT’s, you might want to consider requesting consultation at a University Medical Center staffed by physicians with a specific interest in problems such as yours and extensive experience in the management of this condition.
The following is a report from such an institution. I suggest that you either arrange for an appointment in this clinic or call the author of the report for recommendations of other physician groups, located closer to where you live.
Good luck,
Authors Greiner AN. Meltzer EO.
Authors Full Name Greiner, Alexander N. Meltzer, Eli O.
Institution Allergy and Asthma Medical Group and Research Center, 5776 Ruffin Road, San Diego 92123 Suite B, San Diego, CA 92123, USA. ***@****
Title Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. [Review]
Source Proceedings of the American Thoracic Society. 8(1):121-31, 2011 Mar.
Abstract Allergic rhinitis (AR) and nonallergic rhinopathy (NAR) represent common nasal conditions affecting millions of individuals across the world. Although patients present with similar symptomatology, those with NAR are frequently affected only after childhood and present with a lack of other comorbid atopic disorders such as asthma, atopic dermatitis, and food allergies. Patients with pure NAR usually have no identifiable specific allergen sensitivity, whereas those with mixed (allergic and nonallergic) rhinitis are sensitized to aeroallergens in a manner that does not fully explain the duration or extent of their symptoms. This review presents the diverse options of currently available pharmacologic agents for the treatment of AR and NAR, including intranasal corticosteroids, H(1)-antihistamines, decongestants, cromolyn sodium, antileukotrienes, anticholinergics, capsaicin, anti-IgE, and intranasal saline, in addition to subcutaneous immunotherapy. Furthermore, treatment algorithms for AR and NAR are presented with a stepped-up, stepped-down scheme to aid the clinician in choosing appropriate therapy.
Publication Type Comparative Study. Journal Article. Review.
Date Created 20110302
Year of Publication 2011
Annotation(s)
My Projects
• Complete Reference
• [Find Similar]
• [Find Citing Articles]
• Full Text
Re: Extremely dry nose - disease referred to is Wegener's Granulomatosis.